Q1 2025 Earnings Conference Call April 24, 2025 8:30 AM ET. Company Participants. Matthew Flannery - President & Chief Executive Officer Ted Grace ...

Dyne anticipates filing a Biologics License Application (BLA) submission for US accelerated approval in early 2026.